title: [Treatment of rheumatic diseases: current status and future prospective. Topics: II. Immunosuppressant/antirheumatic drugs; 6. Bucillamine and gold (gold sodium thiomalate and auranofin)].
authors.affiliation: Department of Rheumatology, Niigata Rheumatic Center, Japan.
authors.forename: Satoshi
authors.initials: S
authors.lastname: Ito
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000178:diet therapy*; D001310:Auranofin / Q000627:therapeutic use*; D003545:Cysteine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006052:Gold Sodium Thiomalate / Q000627:therapeutic use*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D018501:Antirheumatic Agents; D006052:Gold Sodium Thiomalate; D001310:Auranofin; D003545:Cysteine; C026535:bucillamine